While there is an increasing trend for single-arm trials, payers prefer to see comparative trials as often as possible, Johan Pontén from the Dental and Pharmaceutical Benefits Agency (TLV) in Sweden said in the high-level stakeholder debate at the PPRI Conference.
← all excerpts
'We need to be part of the solution': lessons from the 2024 PPRI Conference on ensuring access to affordable medicines through innovative policies.
1
—
—